ArticleThe Journal of clinical investigation2007

Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity.

Vincenzo Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.